Octreotide Use in a Patient with MEN-1 Syndrome and Multifocal Pancreatic Neuroendocrine Tumors: A Case Report and Review of the Literature
Showing serum pancreatic polypeptide (PP) levels (pg/mL) over time. Octreotide treatment was initiated in February 2014. Since initiation of octreotide treatment, the PP levels remain stable. Reference range PP (0.0-418.0â€‰pg/mL).
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.